How Best to Deliver Aerosol Medications to Mechanically Ventilated Patients

Clinics in Chest Medicine

Volumn 29, Issue 2, 2008, Pages 277-296

  Dhand, Rajiv ^a,b,c   Guntur, Vamsi P ^a,c  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPALMITOYLPHOSPHATIDYLCHOLINE; DORNASE ALFA; FENOTEROL; FLUORINATED HYDROCARBON; ILOPROST; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LEVALBUTEROL; MUCOLYTIC AGENT; ORCIPRENALINE; PROCATEROL; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; RIBAVIRIN; SALBUTAMOL; SALBUTAMOL SULFATE; UNIPROST;

AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; DOSIMETRY; DRUG DELIVERY SYSTEM; HUMIDITY; HYPERINFLATION; METERED DOSE INHALER; NEBULIZER; PARTICLE SIZE; PATIENT MONITORING; PATIENT POSITIONING; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW;

AEROSOLS; HUMANS; NEBULIZERS AND VAPORIZERS; RESPIRATION, ARTIFICIAL;

EID: 42649121348     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.02.003     Document Type: Review

References (153)

1. MacIntyre N.R., Silver R.M., Miller C.W., et al. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 13 (1985) 81-84
2. Fuller H.D., Dolovich M.B., Posmituck G., et al. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis 141 (1990) 440-444
3. Aerosol consensus statement-1991. American Association for Respiratory Care. Respir Care 36 9 (1991) 916-921
4. Dhand R. Bronchodilator therapy. In: Tobin M. (Ed). Principles and practice of mechanical ventilation. 2nd edition (2006), McGraw Hill, New York 1277-1310
5. Dhand R., and Tobin M.J. Inhaled drug therapy in mechanically-ventilated patients. (Pulmonary Perspective). Am J Respir Crit Care Med 156 (1997) 3-10
6. Dhand R. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically-ventilated patients. Respir Care 50 10 (2005) 1331-1344 [discussion: 1344-45]
7. Dhand R., and Sohal H. Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients. Expert Rev Med Devices 5 1 (2008) 9-18
8. Manthous C.A., Hall J.B., Schmidt G.A., et al. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients. Am Rev Respir Dis 148 (1993) 1567-1570
9. Rau J.L., Harwood R.J., and Groff J.L. Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults: an in vitro study. Chest 102 (1992) 924-930
10. Manthous C.A., Chatila W., Schmidt G.A., et al. Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients. Chest 107 (1995) 210-213
11. Dhand R., Jubran A., and Tobin M.J. Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med. 151 6 (1995) 1827-1833
12. Dhand R., Duarte A.G., Jubran A., et al. Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 154 (1996) 388-393
13. Waugh J.B., Jones D.F., Aranson R., et al. Bronchodilator response with use of OptiVent versus Aerosol Cloud Enhancer metered-dose inhaler spacers in patients receiving ventilatory assistance. Heart Lung 27 (1998) 418-423
14. Mouloudi E., Katsanoulas K., Anastasaki M., et al. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause. Eur Respir J 12 (1998) 165-169
15. Mouloudi E., Katsanoulas K., Anastasaki M., et al. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume. Intensive Care Med 25 (1999) 1215-1221
16. Guerin C., Chevre A., Dessirier P., et al. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 (1999) 1036-1042
17. Mouloudi E., Prinianakis G., Kondili E., et al. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern. Eur Respir J 16 (2000) 263-268
18. Duarte A.G., Momii K., and Bidani A. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response. Respir Care 45 7 (2000) 817-823
19. Tzoufi M., Mentzelopoulos S.D., Roussos C., et al. The effects of nebulized salbutamol, external positive end-expiratory pressure, and their combination on respiratory mechanics, hemodynamics, and gas exchange in mechanically ventilated chronic obstructive pulmonary disease patients. Anesth Analg 101 3 (2005) 843-850
20. Dhand R. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med 21 (2008) 45-60
21. Gay P.C., Patel H.G., Nelson S.B., et al. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 99 (1991) 66-71
22. Bates J.H., and Milic-Emili J. The flow interruption technique for measuring respiratory resistance. J Crit Care 6 (1991) 227-238
23. Dhand R. Bronchodilator delivery with metered-dose inhalers in mechanically ventilated patients. Eur Respir J 9 (1996) 585-595
24. Hendeles L., Colice G.L., and Meyer R.J. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med 356 (2007) 1344-1351
25. Food and Drug Administration. Use of ozone-depleting substances: removal of essential-use designation. Final rule. Fed Regist 70 (2005) 17167-17192
26. Moren F. Aerosol dosage forms and formulations. In: Moren F., Dolovich M.B., Newhouse M.T., et al. (Eds). Aerosols in medicine: principles, diagnosis and therapy. 2nd edition (1993), Elsevier, Amsterdam 321-350
27. Dockhorn R., Vanden Burgt J.A., Ekholm B.P., et al. Clinical equivalence of a novel non-chlorofluorocarbon containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma. J Allergy Clin Immunol 96 (1995) 50-56
28. Vervaet C., and Byron P.R. Drug-surfactant-propellant interactions in HFA formulations. Int J Pharm 186 1 (1999) 13-20
29. Leach C. Enhanced drug delivery through reformulating MDIs with HFA propellants-drug deposition and its effect on preclinical and clinical programs. Respiratory Drug Delivery V (1996), Interpharm Press Inc., Buffalo Grove (IL) p. 133-44
30. Ross D.L., and Gabrio B.J. Advances in metered-dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. J Aerosol Med 12 (1999) 151-160
31. Lewis D.A., Ganderton D., Meakin B.J., et al. Theory and practice with solution systems. In: Dalby R.N., Byron P.R., Peart J., et al. (Eds). Respiratory drug delivery IX (2004), Davis Healthcare International, River Grove (IL) 109-115
32. Leach C.L., Davidson P.J., and Boudreau R.J. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with the CFC-beclomethasone. Eur Respir J 12 (1998) 1346-1353
33. Gross G., Thompson P.J., Chervinsky P., et al. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma. Chest 115 (1999) 343-351
34. Schultz R.K. Drug delivery characteristics of metered-dose inhalers. J Allergy Clin Immunol 96 (1995) 284-287
35. Williams G. Moisture transport into chlofluorocarbon-free metered-dose inhalers. J Allergy Clin Immunol 104 (1999) S227-S229
36. Bleecker E.R., Tinkelman D.G., Ramsdell J., et al. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics. Chest 113 (1998) 283-289
37. Shapiro G.S., Klinger N.M., Ekholm B.P., et al. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorcarbons-11/12 (CFC) albuterol in children with asthma. J Asthma 37 (2000) 667-675
38. Bronsky E., Ekholm B.P., Klinger N.M., et al. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol. J Asthma 36 (1999) 107-114
39. Lumry W., Noveck R., Weinstein S., et al. Switching from ventolin CFC to ventolin HFA is well tolerated and effective in patients with asthma. Ann Allergy Asthma Immunol 86 (2001) 297-303
40. Parameswaran K., Inman M.D., Ekholm B.P., et al. Protection against methacholine bronchoconstriction to assess relative potency of inhaled β2-agonist. Am J Respir Crit Care Med 160 (1999) 354-357
41. Salat D., Popov D., and Sykes A.P. Equivalence of salbutamol 200 μg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Respir Med 94 (2000) S22-S28
42. Baumgarten C.R., Dorow P., Weber H.H., et al. Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Respir Med 94 (2000) S17-S21
43. Ayres J.G., Frost C.D., Holmes W.F., et al. Postmarketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicines guidelines. BMJ 317 (1998) 926-930
44. Craig-McFeely P.M., Wilton L.V., Soriano J.B., et al. Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA 134a in England. Int J Clin Pharmacol Ther 41 (2003) 67-76
45. Harrison L.I., Cline A., Wells T.M., et al. Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free system. Ther Drug Monit 18 (1996) 240-244
46. Rubin B.K., and Fink J.B. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir Care 50 (2005) 1191-1197
47. Bishop M.J., Larson R.P., and Buschman D.L. Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/adapter used. Anesthesiology 73 (1990) 1263-1265
48. Diot P., Morra L., and Smaldone G.C. Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 152 (1995) 1391-1394
49. Fuller H.D., Dolovich M.B., Turpie F.H., et al. Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients. A study comparing four different actuator devices. Chest 105 (1994) 214-218
50. Rau J.L., Dunlevy C.L., and Hill R.L. A comparison of inline MDI actuators for delivery of a beta agonist and a corticosteroid with a mechanically-ventilated lung model. Respir Care 43 (1998) 705-712
51. Fink J.B., Dhand R., Grychowski J., et al. Reconciling in-vitro and in-vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation, and defining efficiency enhancing factors. Am J Respir Crit Care Med 159 (1999) 63-68
52. Barry P.W., and O'Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations with different spacer devices. Eur Respir J 10 (1997) 1345-1348
53. Gabrio B.J., Stein S.W., and Velasquez D.J. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm 186 (1999) 3-12
54. Mitchell J.P., Nagel M.W., Wiersema K.J., et al. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically-ventilated patient: a laboratory study. Respir Care 48 (2003) 1025-1032
55. Wildhaber J.H., Hayden M.J., Dore N.D., et al. Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits. Chest 113 (1998) 186-191
56. Lugo R.A., Kenney J.K., Keenan J., et al. Albuterol delivery in a naeonatal ventilated lung model. Pediatr Pulmonol 31 (2001) 247-254
57. Newman S., Pitcairn G., Steed K., et al. Deposition of fenoterol from metered-dose inhalers containing hydrofluoroalkanes. J Allergy Clin Immunol 104 6 (1999) S253-S257
58. Crompton G.K. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 63 Suppl 119 (1982) 57-65
59. Brown B.A.S. Dispelling the myths of MDIs. Drug Delivery technology 2 7 (2002) 1-7
60. Cyr T.D., Graham S.J., Li K.Y., et al. Low first-spray drug content in albuterol metered-dose inhalers. Pharm Res 8 (1991) 658-660
61. Clark A.R. MDIs: physics of aerosol formation. J Aerosol Med 9 Suppl 1 (1996) S19-S26
62. Versteeg HK, Hargrave GK, Wigley G. The physics of aerosol formulation by pMDI: an update. Proceedings of Drug Delivery to the Lungs XIII. Portishead: The Aerosol Society;2002;60-66.
63. Bamber M.G. Difficulties with CFC-free salbutamol inhaler. Lancet 348 (1996) 1737
64. Rubin B.K., and Dorotype L. How do patients determine that their metered-dose inhaler is empty?. Chest 126 (2004) 1134-1137
65. Food and Drug administration. Use of ozone-depleting substances: removal of essential use designations. Fed Regist 69 115 (2004) 33602-33618
66. Dhand R. Inhalation therapy in invasive and noninvasive mechanical ventilation. Curr Opin Crit Care 13 1 (2007) 27-38
67. Dhand R. The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia. Respir Care 52 7 (2007) 866-884
68. Diot P., Magro P., Vecellio L., et al. Advances in our understanding of aerosolized iloprost for pulmonary hypertension. J Aerosol Med 19 3 (2006) 406-407
69. Miller D.D., Amin M.M., Palmer L.B., et al. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 168 (2003) 1205-1209
70. Hughes J.M., and Saez J. Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care 32 (1987) 1131-1135
71. Dhand R. Aerosol therapy during mechanical ventilation: getting ready for prime time. Am J Respir Crit Care Med 168 10 (2003) 1148-1149
72. Alvine G.F., Rodgers P., Fitzsimmons K.M., et al. Disposable jet nebulizers. How reliable are they?. Chest 101 2 (1992) 316-319
73. Loffert D.T., Ikle D., and Nelson H.S. A comparison of commercial jet nebulizers. Chest 106 6 (1994) 1788-1792
74. Waldrep J.C., Keyhani K., Black M., et al. Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 105 1 (1994) 106-110
75. Hess D., Fisher D., Williams P., et al. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 110 2 (1996) 498-505
76. Sterk P.J., Plomp A., van de Vate J.F., et al. Physical properties of aerosols produced by several jet- and ultrasonic nebulizers. Bull Eur Physiopathol Respir 20 1 (1984) 65-72
77. Hess D.R., Dillman C., and Kacmarek R.M. In vitro evaluation of aerosol bronchodilator delivery during mechanical ventilation: pressure-control vs. volume control ventilation. Intensive Care Med 29 7 (2003) 1145-1150
78. O'Riordan T.G., Greco M.J., Perry R.J., et al. Nebulizer function during mechanical ventilation. Am Rev Respir Dis 145 5 (1992) 1117-1122
79. O'Doherty M.J., Thomas S.H., Page C.J., et al. Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis 146 (1992) 383-388
80. Harvey C.J., O'Doherty M.J., Page C.J., et al. Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation. Thorax 50 1 (1995) 50-53
81. Rau J.L. Design principles of liquid nebulization devices currently in use. Respir Care 47 (2002) 1257-1275 [discussion: 1275-78]
82. Greenspan B.J. Ultrasonic and electrohydrodynamic methods for aerosol generation. In: Hickey A.J. (Ed). Inhalation aerosols: physical and biologic basis for therapy. Lung Biology in Health and Disease vol. 94 (1996), Marcel Dekker, New York 313-335
83. Harvey C.J., O'Doherty M.J., Page C.J., et al. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J 10 (1997) 905-909
84. Phillips G.D., and Millard F.J. The therapeutic use of ultrasonic nebulizers in acute asthma. Respir Med 88 (1994) 387-389
85. Phipps P.R., and Gonda I. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. Chest 97 (1990) 1327-1332
86. Steckel H., and Eskandar F. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. Eur J Pharm Sci 19 (2003) 443-455
87. Thomas S.H., O'Doherty M.J., Page C.J., et al. Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am Rev Respir Dis 148 (1993) 872-877
88. Dhand R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 47 (2002) 1406-1416 [discussion: 1416-18]
89. Smaldone G.C. Advances in aerosols: adult respiratory disease. J Aerosol Med 19 (2006) 36-46
90. Van Dyke R.E., and Nikander K. Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb adaptive aerosol delivery systems: an in vitro study. Respir care 52 2 (2007) 184-190
91. Waldrep J.C., Berlinski A., and Dhand R. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer. J Aerosol Med 20 3 (2007) 310-319
92. Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Current Drug Delivery 2008;5, in press.
93. Dolovich M.B., Ahrens R.C., Hess D.R., et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 127 (2005) 335-371
94. Craven D.E., Lichtenberg D.A., Goularte T.A., et al. Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med 77 (1984) 834-838
95. Hamill R.J., Houston E.D., Georghiou P.R., et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 122 (1995) 762-766
96. Ballard J., Lugo R.A., and Salyer J.W. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit. Respir Care 47 (2002) 31-38
97. Chang L.H., Honiden S., Haithcock J.A., et al. Utilization of bronchodilators in ventilated patients without obstructive airways disease. Respir Care 52 2 (2007) 154-158
98. Summer W., Elston R., Tharpe L., et al. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch Intern Med 149 (1989) 618-623
99. Bowton D.L., Goldsmith W.M., and Haponik E.F. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. Chest 101 (1992) 305-308
100. Ely E.W., Baker A.M., Evans G.W., et al. The distribution of costs of care in mechanically ventilated patients with chronic obstructive pulmonary disease. Crit Care Med 28 (2000) 408-413
101. O'Riordan T.G., Palmer L.B., and Smaldone G.C. Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 149 (1994) 214-219
102. Ahrens R.C., Ries R.A., Popendorf W., et al. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol 2 (1986) 19-26
103. Newman S.P. How well do in vitro particle size measurements predict drug delivery in vitro. J Aerosol Med 11 1 (1998) S97-S103
104. Lange C.F., and Finlay W.H. Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation. Am J Respir Crit Care Med 161 (2000) 1614-1618
105. Wilkes A.R. Heat and moisture exchangers: structure and function. Respir Care Clin N Am 4 (1998) 261-279
106. Habib D.M., Garner S.S., and Brandeburg S. Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy 19 (1999) 143-149
107. Goode M.L., Fink J.B., Dhand R., et al. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 163 (2001) 109-114
108. Svartengren M., Anderson M., Philipson K., et al. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res 15 4 (1989) 575-585
109. Anderson M., Svartengren M., Bylin G., et al. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am J Respir Crit Care Med 147 3 (1993) 524-528
110. Hess D.R., Acosta F.L., Ritz R.H., et al. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 115 (1999) 184-189
111. Crogan S.J., and Bishop M.J. Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology 70 (1989) 1008-1010
112. Dhand R. Special problems in aerosol delivery: artificial airways. Respir Care 45 (2000) 636-645
113. Fink J.B., Dhand R., Duarte A.G., et al. Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in vitro model. Am J Respir Crit Care Med 154 (1996) 382-387
114. Dhand R. Maximizing aerosol delivery during mechanical ventilation: go with the flow and go slow. Intensive Care Med 29 (2003) 1041-1042
115. McPeck M., O'Riordan T.G., and Smaldone G.C. Predicting aerosol delivery to intubated patients: influence of choice of mechanical ventilator on nebulizer efficiency. Respir Care 38 8 (1993) 887-895
116. Dolovich M.A. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir Care 45 (2000) 597-608
117. Fink J.B., and Dhand R. Aerosol therapy in mechanically ventilated patients: recent advances and new techniques. Semin Respir Crit Care Med 21 3 (2000) 183-201
118. Guerin C., Durand P.G., Pereira C., et al. Effects of inhaled fenoterol and positive end-expiratory pressure on the respiratory mechanics of patients with chronic obstructive pulmonary disease. Can Respir J 12 6 (2005) 329-335
119. Duarte A.G., Dhand R., Reid R., et al. Serum albuterol levels in mechanically ventilated patients and healthy subjects after metered-dose inhaler administration. Am J Respir Crit Care Med 154 (1996) 1658-1663
120. Marik P., Hogan J., and Krikorian J. A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients. Chest 115 (1999) 1653-1657
121. Newman S.P., Pavia D., Morén F., et al. Deposition of pressurized aerosols in the human respiratory tract. Thorax 36 1 (1981) 52-55
122. Dolovich M., Ruffin R.E., Roberts R., et al. Optimal delivery of aerosols from metered dose inhalers. Chest 80 6 Suppl (1981) 911-915
123. Vecellio L., Guérin C., Grimbert D., et al. In vitro study and semiempirical model for aerosol delivery control during mechanical ventilation. Intensive Care Med 31 6 (2005) 871-876
124. Fink J. Aerosol drug therapy. In: Wilkins R.L., Stoller J.K., and Scanlan C.L. (Eds). Egan's fundamentals of respiratory care. 8th edition (2003), Mosby, St. Louis (MO) 761-800
125. Boucher B.A., Kuhl D.A., Coffey B.C., et al. Drug use in a trauma intensive-care unit. Am J Hosp Pharm 151 (1990) 1827-1833
126. Wollam P.J., Kasper C.L., Bishop M.J., et al. Prediction and assessment of bronchodilator response in mechanically ventilated patients. Respir Care 39 (1994) 730-735
127. Gay P.C., Rodarte J.R., Tayyab M., et al. Evaluation of bronchodilator responsiveness in mechanically ventilated patients. Am Rev Respir Dis 136 (1987) 880-885
128. Wright P.E., Carmichael L.C., and Bernard G.R. Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest 106 (1994) 1517-1523
129. Morina P., Herrera M., Venegas J., et al. Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med 23 (1997) 58-64
130. Mancebo J., Amaro P., Lorino H., et al. Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis 144 1 (1991) 95-100
131. Bennett W.D. Effect of beta-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol 110 (2002) S291-S297
132. McAuley D.F., Frank J.A., Fang X., et al. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 32 7 (2004) 1470-1476
133. Fernandez A., Munoz J., de la Calle B., et al. Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med 20 (1994) 199-202
134. Abramson M.J., Walters J., and Walters E.H. Adverse effects of beta-agonists: are they clinically relevant?. Am J Respir Med 2 4 (2003) 287-297
135. Kleerup E.C., Tashkin D.P., Cline A.C., et al. Cumulative dose-response study of non-CFC propellant HFA-134a salbutamol sulfate metered-dose inhaler in patients with asthma. Chest 109 (1996) 702-707
136. Ramsdell J.W., Colice G.L., Ekholm B.P., et al. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ann Allergy Asthma Immunol 81 (1998) 593-599
137. Dhand R. Bronchodilator therapy in mechanically ventilated patients: patient selection and clinical outcomes. Respir Care 52 2 (2007) 152-153
138. Carlucci A., Richard J.C., Wysocki M., et al. Noninvasive versus conventional mechanical ventilation: an epidemiologic survey. Am J Respir Crit Care Med 163 (2001) 874-880
139. Brochard L., Mancebo J., Wysocki M., et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 333 13 (1995) 817-822
140. Bott J., Carroll M.P., Conway J.H., et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 341 8860 (1993) 1555-1557
141. Kramer N., Meyer T.J., Meharg J., et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 151 6 (1995) 1799-1806
142. Ram F.S., Picot J., Lightowler J., et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3 (2004) CD004104
143. Ferrer M., Valencia M., Nicolas J.M., et al. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med 173 2 (2006) 164-170
144. Shenfield G.M., Evans M.E., Walker S.R., et al. The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients. Am Rev Respir Dis 108 3 (1973) 501-505
145. Parkes S.N., and Bersten A.D. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax 52 2 (1997) 171-175
146. Dolovich M.B., Killian D., Wolff R.K., et al. Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis 115 3 (1977) 397-402
147. Hess D.R. The mask for noninvasive ventilation: principles of design and effects on aerosol delivery. J Aerosol Med 20 Suppl 1 (2007) S85-S99
148. Chatmongkolchart S., Schettino G.P., Dillman C., et al. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position. Crit Care Med 30 11 (2002) 2515-2519
149. Fauroux B., Itti E., Pigeot J., et al. Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. Am J Respir Crit Care Med 162 6 (2000) 2265-2271
150. Branconnier M.P., and Hess D.R. Albuterol delivery during noninvasive ventilation. Respir Care 50 12 (2005) 1649-1653
151. Nava S., Karakurt S., Rampulla C., et al. Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a randomized, controlled study. Intensive Care Med 27 10 (2001) 1627-1635
152. Pollack Jr. C.V., Fleisch K.B., and Dowsey K. Treatment of acute bronchospasm with beta-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit. Ann Emerg Med 26 5 (1995) 552-557
153. Jolliet P., Tassaux D., Roeseler J., et al. Helium-oxygen versus air-oxygen noninvasive pressure support in decompensated chronic obstructive disease: a prospective, multicenter study. Crit Care Med 31 3 (2003) 878-884